Predicting response and toxicity to PD-1 inhibition using serum autoantibodies identified from immuno-mass spectrometry.
Music M, Iafolla M, Soosaipillai A, Batruch I, Prassas I, Pintilie M, Hansen AR, Bedard PL, Lheureux S, Spreafico A, Razak AA, Siu LL, Diamandis EP.
Music M, et al. Among authors: diamandis ep.
F1000Res. 2020 May 7;9:337. doi: 10.12688/f1000research.22715.1. eCollection 2020.
F1000Res. 2020.
PMID: 33299547
Free PMC article.
Clinical Trial.